Skip to main content

Sars-cov-2 (covid-19) Mrna-lnp Vaccine (cvx 309) Side Effects

Applies to sars-cov-2 (covid-19) mrna-lnp vaccine (cvx 309): intramuscular suspension.

General adverse events

The most commonly reported side effects included injection site pain, fatigue, and headache.[Ref]

Cardiovascular

Dermatologic

Gastrointestinal

Hematologic

Hypersensitivity

Local

Metabolic

Musculoskeletal

Nervous system

Other

References

1. (2023) "Product Information. Comirnaty (2023-2024) PF (cvx 309) (SARS-CoV-2 (COVID-19) mRNA-LNP vaccine (cvx 309))." Pfizer U.S. Pharmaceuticals Group

2. (2024) "Product Information. Comirnaty (2024-2025) PF (cvx 309) (SARS-CoV-2 (COVID-19) mRNA-LNP vaccine (cvx 309))." Pfizer U.S. Pharmaceuticals Group

More about sars-cov-2 (covid-19) mrna-lnp vaccine (cvx 309)

Further information

Sars-cov-2 (covid-19) mrna-lnp vaccine (cvx 309) side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Note: Medication side effects may be underreported. If you are experiencing side effects that are not listed, submit a report to the FDA by following this guide.